Weight Loss Drug Ban Upheld (Australia)
This article was originally published in PharmAsia News
Executive Summary
The Australian Federal Court rejected an appeal by top drug manufacturer Roche to reverse a ban preventing them from publicly advertising the weight-loss drug Xenical. The ban was handed down in February by an Australian federal health committee. The committee claimed that Xenical should not be publicly advertised because they felt Roche's marketing campaign might pressure pharmacists to give the drug to individuals it was not designed for, particularly teenagers. Xenical is intended to reduce the weight of extremely obese individuals but it can also have some unwanted side effects, like nausea and abdominal pain. (Click here for more - May Require Free Registration
|
The Australian Federal Court rejected an appeal by top drug manufacturer Roche to reverse a ban preventing them from publicly advertising the weight-loss drug Xenical. The ban was handed down in February by an Australian federal health committee. The committee claimed that Xenical should not be publicly advertised because they felt Roche's marketing campaign might pressure pharmacists to give the drug to individuals it was not designed for, particularly teenagers. Xenical is intended to reduce the weight of extremely obese individuals but it can also have some unwanted side effects, like nausea and abdominal pain. (Click here for more - May Require Free Registration)
"Weight Loss Drug Ban
Upheld"
|